Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT06315556
Eligibility Criteria:
Inclusion Criteria:
* Eligible infants within the NNRD include those who were:
* 1\. Born during the study period, i.e. from Q4/2023 following market introduction of Eylea PFS+PDD and 31st December 2026, and
* 2\. Received care in a neonatal unit that contributes data to the NNRD and the unit has agreed to participate in the study, and
* 3\. Diagnosed with ROP in any stage in at least one eye.
Exclusion Criteria:
* Infants with missing data for gestational age at birth will be excluded.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
1 Year
Study:
NCT06315556
Study Brief:
Protocol Section:
NCT06315556